Crunching the numbers for INDV... Refresh in a moment for the full analysis.
Indivior Pharmaceuticals, Inc. (INDV)
Healthcare
healthy
$30.54
Updated: 2026-04-12
60
TradeApes Score
add
Financial Strength
55
Mixed
Operating Trend
73
Healthy
Valuation
60
Healthy
Capital Allocation
55
Mixed
Risk
50
Mixed
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
Altman Z-Score in distress zone — elevated bankruptcy risk
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.